Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 90 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8188281

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 29, 2012 · Expires May 24, 2032

    granted
  2. US 8188275

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 29, 2012 · Expires May 24, 2032

    granted
  3. US 8178543

    Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 15, 2012 · Expires May 10, 2032

    granted
  4. US 8178555

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 15, 2012 · Expires May 10, 2032

    granted
  5. US 8178534

    cMET inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 15, 2012 · Expires May 10, 2032

    granted
  6. US 8178513

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted
  7. US 8173663

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 8, 2012 · Expires May 3, 2032

    granted
  8. US 8173360

    Cell death inhibitor

    Takeda Pharmaceutical Company Limited · Granted May 8, 2012 · Expires May 3, 2032

    granted
  9. US 8173635

    Kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 8, 2012 · Expires May 3, 2032

    granted
  10. US 8168636

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  11. US 8168415

    Axl fusion proteins as Axl tyrosine kinase inhibitors

    The Regents of the University of Colorado · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  12. US 8168798

    Caspase inhibitor prodrugs

    Vertex Pharmaceuticals Incorporated · Granted May 1, 2012 · Expires Apr 26, 2032

    granted
  13. US 8163732

    Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  14. US 8163917

    Azaindoles useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  15. US 8163509

    Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  16. US 8158627

    Compositions and treatments using pyridazine compounds and cholinesterase inhibitors

    Northwestern University · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  17. US 8158658

    Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted
  18. US 8153644

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  19. US 8153655

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  20. US 8148378

    Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal

    Xenon Pharmaceuticals Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  21. US 8148367

    Renin inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  22. US 8143445

    HDAC inhibitors

    Lixte Biotechnology, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  23. US 8143252

    Tetrahalogenated compounds useful as inhibitors of angiogenesis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  24. US 8143412

    Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

    The Board of Regents of the University of Texas System · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted